• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾源性尿崩症(NDI):5 例巴西患者的临床、实验室和遗传学特征。

Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients.

机构信息

Unidade de Nefrologia Pediátrica, Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Clinics (Sao Paulo). 2009 May;64(5):409-14. doi: 10.1590/s1807-59322009000500007.

DOI:10.1590/s1807-59322009000500007
PMID:19488606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2694244/
Abstract

INTRODUCTION

Nephrogenic diabetes insipidus is characterized by a lack of response in the distal nephron to the antidiuretic hormone arginine vasopressin. Manifestations include polyuria, polydipsia, hyposthenuria, recurrent episodes of dehydration and fever and growth failure. Most cases are caused by mutations in the AVPR2 gene. The mutant receptors are trapped intracellularly.

METHOD

We studied five boys using clinical, laboratory and molecular data. The mean age at diagnosis was 14.6 months (range 6 to 24) and 12.2 years (7.8 to 19) after the follow-up period. The mean period of follow-up was 132.2 +/- 50.9 months.

RESULTS

The geometric means of the z-scores of weight and stature were -4.5 and -3.6, respectively, at diagnosis. At the last medical appointment, the z-scores of weight and stature were -0.3 and -0.9, respectively. Three patients were diagnosed with ureterohydronephrosis and exhibited increased post-void urine volume. Mutations in the AVPR2 gene were found in all patients, and the carrier status was confirmed in four of five cases. Two unrelated children presented identical mutations (S167L) in arginine vasopressin R2. Two of the patients had a mutation that has already been described in other Brazilian families (R337X), and one patient showed a de novo mutation (Y128D) in arginine vasopressin R2, since his mother's molecular analysis was normal. The recurrence risk for this family was significantly reduced.

CONCLUSION

This study reports the clinical and laboratory characterization of Nephrogenic diabetes insipidus and reiterates the importance of the genetic basis that underlies the disease diagnosis and genetic counseling.

摘要

介绍

肾性尿崩症的特征是远曲小管对血管加压素精氨酸加压素无反应。临床表现包括多尿、多饮、少尿、反复脱水和发热以及生长发育不良。大多数病例是由 AVPR2 基因突变引起的。突变受体被困在细胞内。

方法

我们使用临床、实验室和分子数据研究了 5 名男孩。诊断时的平均年龄为 14.6 个月(范围为 6 至 24),随访期后为 12.2 岁(7.8 至 19)。平均随访时间为 132.2 +/- 50.9 个月。

结果

诊断时体重和身高的 Z 分数几何平均值分别为-4.5 和-3.6。最后一次就诊时,体重和身高的 Z 分数分别为-0.3 和-0.9。3 名患者被诊断为输尿管积水,表现为排尿后尿量增加。所有患者均发现 AVPR2 基因突变,5 例中有 4 例证实为携带者状态。2 名无关的儿童表现出相同的精氨酸加压素 R2 突变(S167L)。2 名患者具有已在其他巴西家族中描述过的突变(R337X),1 名患者显示出精氨酸加压素 R2 中的新生突变(Y128D),因为他母亲的分子分析正常。该家族的复发风险显著降低。

结论

本研究报告了肾性尿崩症的临床和实验室特征,并再次强调了疾病诊断和遗传咨询所依据的遗传基础的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6816/2694244/b8e36b323d21/cln64_5p409f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6816/2694244/b8e36b323d21/cln64_5p409f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6816/2694244/b8e36b323d21/cln64_5p409f1.jpg

相似文献

1
Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients.肾源性尿崩症(NDI):5 例巴西患者的临床、实验室和遗传学特征。
Clinics (Sao Paulo). 2009 May;64(5):409-14. doi: 10.1590/s1807-59322009000500007.
2
Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).肾性尿崩症(NDI)的遗传形式:血管加压素受体缺陷(X连锁)和水通道蛋白缺陷(常染色体隐性和显性)。
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):263-76. doi: 10.1016/j.beem.2016.02.010. Epub 2016 Mar 2.
3
Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.巴西肾性尿崩症患者中新型血管加压素2型(AVPR2)基因突变
Genet Test. 2006 Fall;10(3):157-62. doi: 10.1089/gte.2006.10.157.
4
Nephrogenic diabetes insipidus.肾性尿崩症
Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006.
5
V2R mutations and nephrogenic diabetes insipidus.V2R 突变与肾性尿崩症。
Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7.
6
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.一种新的AVPR2剪接位点突变导致两兄弟患部分性X连锁肾性尿崩症。
Eur J Pediatr. 2016 May;175(5):727-33. doi: 10.1007/s00431-015-2684-4. Epub 2016 Jan 21.
7
Nephrogenic diabetes insipidus.肾性尿崩症
Am J Med. 1998 Nov;105(5):431-42. doi: 10.1016/s0002-9343(98)00301-5.
8
A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.一个土耳其家族中因AVPR2基因大片段缺失导致严重的肾性尿崩症
Endocrine. 2014 May;46(1):148-53. doi: 10.1007/s12020-013-0043-7. Epub 2013 Sep 13.
9
AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.AQP2:与先天性肾性尿崩症相关的突变及翻译后修饰和蛋白-蛋白相互作用的调节。
Cells. 2020 Sep 26;9(10):2172. doi: 10.3390/cells9102172.
10
Nephrogenic diabetes insipidus.肾性尿崩症
Annu Rev Physiol. 2001;63:607-30. doi: 10.1146/annurev.physiol.63.1.607.

引用本文的文献

1
Impact of chemical preservative in urine samples.化学防腐剂对尿液样本的影响。
EJIFCC. 2020 Mar 20;31(1):56-64. eCollection 2020 Mar.
2
A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidus.伴有严重肾性尿崩症的AVPR2基因新发错义突变。
NDT Plus. 2010 Dec;3(6):542-4. doi: 10.1093/ndtplus/sfq158. Epub 2010 Sep 9.
3
Congenital nephrogenic diabetes insipidus: the current state of affairs.先天性肾性尿崩症:现状。

本文引用的文献

1
Long-term growth of children with nephrogenic diabetes insipidus.肾源性尿崩症患儿的长期生长情况。
Pediatr Nephrol. 2008 Nov;23(11):2007-12. doi: 10.1007/s00467-008-0844-8. Epub 2008 Jun 27.
2
Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.巴西肾性尿崩症患者中新型血管加压素2型(AVPR2)基因突变
Genet Test. 2006 Fall;10(3):157-62. doi: 10.1089/gte.2006.10.157.
3
Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Pediatr Nephrol. 2012 Dec;27(12):2183-204. doi: 10.1007/s00467-012-2118-8. Epub 2012 Mar 17.
4
Nocturia × disturbed sleep: a review.夜尿症×睡眠障碍:一篇综述。
Int Urogynecol J. 2012 Mar;23(3):255-67. doi: 10.1007/s00192-011-1525-x. Epub 2011 Aug 17.
药物伴侣对MDCK细胞中血管加压素V2受体突变体的功能挽救:与肾性尿崩症治疗的相关性
Am J Physiol Renal Physiol. 2007 Jan;292(1):F253-60. doi: 10.1152/ajprenal.00247.2006. Epub 2006 Aug 22.
4
Body water homeostasis: clinical disorders of urinary dilution and concentration.机体水平衡:尿液稀释与浓缩的临床紊乱
J Am Soc Nephrol. 2006 Jul;17(7):1820-32. doi: 10.1681/ASN.2006030240. Epub 2006 May 31.
5
Nephrogenic diabetes insipidus.肾性尿崩症
Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006.
6
Molecular biology of hereditary diabetes insipidus.遗传性尿崩症的分子生物学
J Am Soc Nephrol. 2005 Oct;16(10):2836-46. doi: 10.1681/ASN.2005040371. Epub 2005 Aug 10.
7
V2 receptor antagonists in cystic kidney diseases: an exciting step towards a practical treatment.囊性肾病中的V2受体拮抗剂:迈向实际治疗的激动人心的一步。
J Am Soc Nephrol. 2005 Apr;16(4):838-9. doi: 10.1681/ASN.2005020136. Epub 2005 Feb 23.
8
Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.氢氯噻嗪对锂诱导的肾性尿崩症的抗利尿作用与水通道蛋白-2、钠-氯共转运体和上皮钠通道的上调有关。
J Am Soc Nephrol. 2004 Nov;15(11):2836-43. doi: 10.1097/01.ASN.0000143476.93376.04.
9
Nephrogenic diabetes insipidus: update of genetic and clinical aspects.肾性尿崩症:遗传与临床方面的最新进展
Nephrol Dial Transplant. 2004 Jun;19(6):1351-3. doi: 10.1093/ndt/gfh172. Epub 2004 Mar 5.
10
Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.非肽类血管加压素受体拮抗剂:选择性及口服活性V1a、V2和V1b受体配体的研发
Prog Brain Res. 2002;139:197-210. doi: 10.1016/s0079-6123(02)39017-4.